Osteoarthritis Trial, Recruiting NCT06986694 Sponsor: Riphah International University Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT06986694
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 45 and 65 years old
  • Both men and women are eligible
  • People who have had knee pain lasting at least 3 months
  • People whose knee pain during walking rates at least 2 out of 10 on a pain scale
  • People who have difficulty with walking and balance, as measured by a standard movement test called the Timed Up & Go (TUG) test
  • People who score poorly on the WOMAC scale, which measures knee pain, stiffness, and ability to do everyday physical activities
  • People diagnosed with Grade II knee osteoarthritis, as determined by a method called the Kellgren-Lawrence grading system
  • People who are willing and able to give their informed consent to take part in the study

Who may not be able to join:

  • People under 45 or over 65 years of age
  • People whose knee pain during walking rates 9 out of 10 or higher on a pain scale
  • People diagnosed with Grade I, III, or IV knee osteoarthritis using the Kellgren-Lawrence grading system
  • People with a physical or mental health condition that severely affects their daily life
  • People for whom exercise therapy is not considered safe or appropriate (confirm with trial site)
  • People who may have widespread long-term pain affecting multiple areas of the body, including both sides, above and below the waist, and the spine
  • People who have already had a total knee replacement, or who are currently on a waiting list for one, in either knee
  • People whose knee pain is caused by something other than osteoarthritis, such as rheumatoid arthritis or gout
  • People who have received injections into the knee joint (such as steroid or hyaluronic gel injections) within the past 6 months for knee pain

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hira Shaukat, TDPT, Riphah International University

Phone: 03324390125

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
12 June 2025
Est. completion
1 September 2025

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Numeric Pain Rating Scale; The Western Ontario and McMaster Universities Osteoarthritis Index

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov